Structure-forward targeting of claudins with synthetic binders
1Department of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, USA.
FEBS Letters
|August 6, 2026
Summary
Developing targeted therapies for claudins, proteins regulating cell transport, is challenging. Understanding claudin assembly and structure is crucial for designing effective biologic and small molecule binders for tight junction therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Claudins are key proteins in tight junctions, controlling paracellular transport in epithelial and endothelial tissues.
- Claudin-claudin interactions at extracellular segments are vital for tight junction barrier integrity and function.
- Developing targeted biologic or small molecule binders is difficult due to the small, dynamic nature of claudin extracellular segments and lack of structural data.
Purpose of the Study:
- To review current claudin targeting strategies and recent advancements in molecule development.
- To explore the impact of natural and synthetic molecules on claudin and tight junction biology.
- To provide a structure-forward framework for designing novel claudin-binding molecules.
Main Methods:
- Literature review of claudin targeting strategies.
- Analysis of recent advances in natural and synthetic molecule development.
- Focus on structure-based design principles for claudin binders.
Main Results:
- Identified challenges in developing binders for small, dynamic claudin extracellular segments.
- Highlighted the impact of existing molecules on claudin and tight junction biology.
- Emphasized the importance of understanding claudin assembly and structure for therapeutic development.
Conclusions:
- Therapeutic potential of claudin-targeting molecules hinges on understanding their assembly and structure.
- A structure-forward approach is essential for designing new claudin-binding molecules with diverse functions.
- This review offers a framework to guide the rational design of next-generation claudin-based therapeutics.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Clathrin Coated Vesicles
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...


